Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase 2 study of HRGN Esophageal Implant to study the repair of damage to the esophagus in adults caused by cancer or injury

Next Previous
Trial Profile

A phase 2 study of HRGN Esophageal Implant to study the repair of damage to the esophagus in adults caused by cancer or injury

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 27 Aug 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 27 Aug 2024 New trial record
  • 26 Aug 2024 According to a Harvard Apparatus Regenerative Technology media release, FDA has approved a ten-patient phase one and phase two clinical trial to study the repair of damage to the esophagus in adults caused by cancer or injury. Hence, the Company expects the repair of birth defects in the esophagus to be an additional indication for which HRGN will seek FDA approval.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top